中国寄生虫学与寄生虫病杂志 ›› 2021, Vol. 39 ›› Issue (6): 746-752.doi: 10.12140/j.issn.1000-7423.2021.06.004

• 论著 • 上一篇    下一篇

重组卵形疟原虫裂殖子表面蛋白1 N端的抗原性及免疫原性分析

于嘉利1(), 刘蕾2, 杨博1, 楚瑞林3, 孙毅凡1, 刘耀宝4, 程洋1,*()   

  1. 1 江南大学无锡医学院病原感染与免疫研究室,无锡 214000
    2 江阴市第三人民医院,无锡 214000
    3 上海市疾病预防控制中心,上海 200336
    4 江苏省血吸虫病防治研究所,无锡 214000
  • 收稿日期:2021-03-15 修回日期:2021-05-06 出版日期:2021-12-30 发布日期:2021-12-15
  • 通讯作者: 程洋
  • 作者简介:于嘉利(1996-),女,硕士研究生,从事病原感染与免疫研究。E-mail: 18328089416@163.com
  • 基金资助:
    国家自然科学基金(81871681)

Antigenicity and immunogenicity analysis of the recombinant merozoite surface protein 1 N-terminal of Plasmodium ovale

YU Jia-li1(), LIU Lei2, YANG Bo1, CHU Rui-lin3, SUN Yi-fan1, LIU Yao-bao4, CHENG Yang1,*()   

  1. 1 Laboratory of Pathogen Infection and Immunity, Wuxi School of Medicine, Jiangnan University, Wuxi 214000, China
    2 The Third People’s Hospital of Jiangyin City,Wuxi 214000, China
    3 Shanghai Center for Disease Control and Prevention,Shanghai 200336,China
    4 Jiangsu Institute of Parasite Diseases, Wuxi 214000, China
  • Received:2021-03-15 Revised:2021-05-06 Online:2021-12-30 Published:2021-12-15
  • Contact: CHENG Yang
  • Supported by:
    National Natural Science Foundation of China(81871681)

摘要:

目的 表达卵形疟原虫柯氏亚种(Plasmodium ovale curtisi)和沃氏亚种(P. ovale wallikeri)裂殖子表面蛋白1(merozoite surface protein 1,MSP1)N端重组蛋白,并进行抗原性及免疫原性分析,以探究其作为卵形疟候选疫苗的潜力。 方法 PCR扩增卵形疟原虫基因组DNA Pomsp1 N端基因。将纯化后的Pocmsp1 N端、Powmsp1 N端分别与pET30a、pET32a载体连接,并转化至DH5α感受态细胞中,经BamHⅠ和XhoⅠ双酶切验证且测序无误后,转入大肠埃希菌BL21(DE3)pLysS中。0.1 mmol/L异丙基-β-D-硫代半乳糖苷(IPTG)诱导表达后纯化蛋白,采用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质印迹(Western blotting)检测蛋白表达情况。15只BALB/c小鼠随机分为rPocMSP1 N端组、rPowMSP1 N端组和阴性对照组,每组5只,分别腹腔注射50 μg与弗氏完全佐剂混合的rPocMSP1和rPowMSP1 N端蛋白和等量的PBS,初次免疫后第21天和第42天使用弗氏不完全佐剂加强免疫,初次免疫后第0、7、28和49天采集小鼠尾静脉血,制备血清。ELISA、Western blotting检测小鼠血清中特异性IgG、分析抗体滴度及抗体亲和指数,评估纯化后的rPocMSP1和rPowMSP1 N端蛋白的免疫原性。Western blotting检测rPocMSP1和rPowMSP1 N端蛋白的交叉反应,并用蛋白芯片分析重组蛋白在卵形疟原虫感染者血清中的抗原反应性。采用GraphPad Prism 5.0软件和Microsoft Excel 2016软件进行统计学分析,组间差异比较采用成组t检验。 结果 PCR扩增结果显示,Pocmsp1 N端和Powmsp1 N端片段大小均为1 068 bp,与预期大小一致。PCR产物经克隆、诱导并纯化后,所获rPocMSP1和rPowMSP1 N端蛋白浓度分别为0.5 mg/ml和1.0 mg/ml。SDS-PAGE结果显示,rPocMSP1和rPowMSP1 N端的相对分子质量(Mr)分别约为46 000和59 000,Western blotting结果证实蛋白成功表达。免疫组小鼠血清均可特异性识别相应抗原。ELISA结果显示,在免疫后第7天检测到特异性IgG抗体,纯化的rPocMSP1 N端蛋白和rPowMSP1 N端蛋白均与IgG发生特异性反应,与阴性对照组相比差异均有统计学意义(t = 5.824、25.98,P < 0.01);初次免疫后第28天,rPocMSP1 N端和rPowMSP1 N端蛋白免疫组小鼠血清A450值分别为1.043 ± 0.390和1.923 ± 1.373;IgG抗体水平持续上升至免疫后第49天,rPocMSP1 N端和rPowMSP1 N端蛋白免疫组小鼠血清A450值分别为1.217 ± 0.365和2.463 ± 0.983。rPoMSP1 N端在小鼠体内中诱导了较高的抗体应答,抗体滴度为1 ∶ 640 000至1 ∶ 1 280 000。ELISA结果表明,用rPoMSP1 N端蛋白免疫的小鼠均诱导出高亲和力的IgG抗体,rPocMSP1 N端和rPowMSP1 N端免疫小鼠血清抗体亲和指数分别为97.11%和75.72%。Western blotting结果显示,rPocMSP1 N端免疫组小鼠血清中IgG抗体可以识别rPowMSP1 N端蛋白,rPowMSP1 N端免疫组小鼠血清中IgG抗体可以识别rPocMSP1 N端蛋白,两者存在交叉反应。蛋白芯片分析结果显示,rPocMSP1 N端蛋白识别卵形疟原虫感染者血清的敏感性为83.33%、特异性为57.14%,rPowMSP1 N端识别感染者血清的敏感性为97.62%、特异性为54.76%。rPocMSP1 N端、rPowMSP1 N端均与卵形疟原虫感染者血清有反应,与健康人血清相比,差异具有统计学意义(t = 5.896、10.42,P < 0.01)。 结论 rPoMSP 1 N端蛋白具有良好的免疫原性,可诱导小鼠产生体液免疫应答,与卵形疟原虫感染者血清抗体反应上具有良好的抗原性。

关键词: 卵形疟原虫, 裂殖子表面蛋白1, 免疫原性, 抗原性

Abstract:

Objective This study aims to express the merozoite surface protein 1 N-terminal proteins of Plasmodium ovale curtisi and P. ovale wallikeri, and analyze their antigenicity and immunogenicity, revealing the potential for being as vaccine candidates of P. ovale. Methods The N-terminal of the Pomsp1 gene was amplified from the genomic DNA of P. ovale. The purified N-terminal sequences of Pocmsp1 and Powmsp1 were separately connected to the plasmid pET30a and pET32a and then transfected into DH5α competent cells. After verification with BamHⅠ and XhoⅠ enzyme digestion and DNA sequencing, the gene sequences were transferred into Escherichia coli BL21 (DE3) pLysS. After induction with 0.1 mmol/L IPTG, the expressed proteins were collected, purified, and verified with SDS-PAGE and Western blotting. Fifteen BALB/c mice were randomly assigned into three groups of 5 each: the rPocMSP1 N-terminal protein group, rPowMSP1 N-terminal protein group, and a negative control group. The mice of the three groups were injected intraperitoneally with the recombinant protein of rPocMSP1 N-terminal and rPowMSP1 N-terminal protein (50 μg of recombinant protein emulsified with Freund’s complete adjuvant) respectively, while the control group mice were injected with PBS. On 21d and 42d after primary immunization, the mice were boosted with the corresponding antigens emulsified with Freund’s incomplete adjuvant. Furthermore, on days 0, 7, 28, and 49 after immunization, tail vein blood samples were collected for serum preparation. ELISA and Western blotting were used to determine the serum specific IgG, analyze antibody titer and antibody affinity index, thereby to evaluate the immunogenicity of rPocMSP1 N-terminal and rPowMSP1 N-terminal proteins. Western blotting was used to determine the cross-reaction of the two recombinant proteins, and protein array was used to analyze their antigenicity in the serum of examinees infected with P. ovale. Results PCR demonstrated that the sequence length of PocMSP1 N-terminal and PowMSP1 N-terminal fragment was 1 068 bp, showing concordant with the expected size. Produced by PCR cloning, expression and purification, the concentration of rPocMSP1 N-terminal and rPowMSP1 N-terminal recombinant protein was 0.5 mg/ml and 1.0 mg/ml respectively. SDS-PAGE showed that the relative molecular mass of the purified rPocMSP1 N-terminal and rPowMSP1 N-terminal protein was 46 000 and 59 000, respectively, and Western blotting indicated the recombinant proteins were successfully expressed. The sera of immunized mice could recognize the corresponding antigens. ELISA detected specific IgG antibodies on 7 d after immunization, revealing specific reaction between the purified recombinant proteins and IgG, which was significantly different compared with that in the negative control group (rPocMSP1 N-terminal: t = 5.824, P < 0.01; rPowMSP1 N-terminal: t = 25.98, P < 0.01). On 28 d after immunization, the mean A450 values for serum IgG in groups rPocMSP1 N-terminal and rPowMSP1 N-terminal were 1.043 ± 0.390, and 1.923 ± 1.373, and when the IgG levels continued to rise up to 49 d after immunization the mean A450 values for serum IgG in rPocMSP1 N-terminal was 1.217 ± 0.365, and rPowMSP1 N-terminal was 2.463 ± 0.983. rPoMSP1 N-terminal protein induced considerable immune response in mice, with the antibody titer of 1 ∶ 640 000 and 1 ∶ 1 280 000, respectively.ELISA revealed that rPocMSP1 N-terminal and rPowMSP1 N-terminal proteins induced IgG antibody with high affinities in immunized mice, showing the affinity 97.11% by rPocMSP1 N-terminal protein, and 75.72% by rPowMSP1 N-terminal protein. Western blotting showed that the serum IgG antibody in mice immunized with rPocMSP1 N-terminal could recognize rPowMSP1 N-terminal antigen, and vice versa, the antibody in mice immunized with rPowMSP1 N-terminal antigen could recognize rPocMSP1 N-terminal antigen, demonstrating the two antigens have cross reaction property. Analysis with protein array showed that tested with rPocMSP1 N-terminal protein using P. ovale, the sensitivity and specificity was 83.33% and 57.14%, respectively; while rPowMSP1 N-terminal protein presented 97.62% of sensitivity and 54.76% of specificity; in comparison with the reaction using the sera from normal persons, the difference was statistically significant(t = 5.896, 10.42, P < 0.01). Conclusion rPoMSP1 N-terminal protein showed good immunogenicity, inducing humoral immune response in mice, and displaying significant antigenisity in reacting with the serum of people infected with P. ovale.

Key words: Plasmodium ovale, Merozoite surface protein 1, Immunogenicity, Antigenicity

中图分类号: